Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Myriad Genetics Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 196 | 2 | 190 | −4 |
| Shares | 80.6M | 88.3K | 82.2M | +1.71M (+2.1%) |
| Value | $1.17B | $1.64M | $1.91B | +$742.0M (+63.5%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Myriad Genetics Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 1,588,977 | $36.9M | 0.12% |
| Profund Advisors LLC | 36,397 | $845.5K | 0.05% |
| First Trust Advisors LP | 34,176 | $793.9K | 0.00% |
| Oppenheimer & Co Inc | 15,680 | $364.2K | 0.01% |
| Vident Investment Advisory, LLC | 14,008 | $325.4K | 0.01% |
| Amundi | 11,398 | $265.1K | 0.00% |
| Centiva Capital, LP | 10,402 | $241.6K | 0.01% |
| World Equity Group, Inc. | 21,858 | $230.2K | 0.04% |
| PEAK6 Investments LLC | 9,900 | $230.0K | 0.01% |
| CIBC Asset Management Inc | 8,993 | $208.9K | 0.00% |
| Group One Trading, L.P. | 5,397 | $125.4K | 0.01% |
| State of Wyoming | 1,617 | $37.6K | 0.01% |
| Stone House Investment Management, LLC | 1,000 | $23.2K | 0.01% |
| Sageworth Trust Co | 320 | $7.43K | 0.00% |
| Massmutual Trust Co FSB | 267 | $6.20K | 0.00% |
| Bokf, NA | 144 | $3.35K | 0.00% |
| Ridgewood Investments LLC | 101 | $2.33K | 0.00% |
| Lindbrook Capital, LLC | 74 | $1.72K | 0.00% |
| Morton Brown Family Wealth, LLC | 55 | $1.28K | 0.00% |
| Bell Investment Advisors, Inc | 48 | $1.12K | 0.00% |
| Belpointe Asset Management LLC | 35 | $813 | 0.00% |
| Signaturefd, LLC | 11 | $256 | 0.00% |
| AdvisorNet Financial, Inc | 8 | $186 | 0.00% |
Sold out (27)
Institutions that held Myriad Genetics Inc at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (2)
Institutions that held Myriad Genetics Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 88,269 | $1.64M |
| Trustcore Financial Services, LLC | 42 | $609 |